Loading...
The importance of post-traumatic stress disorder (PTSD) in terms of distress and disability has been magnified by the events of September 11th. Sertraline is approved by the FDA for the acute treatment of PTSD; however, we have little information about the usefulness of treatment for patients with chronic PTSD, which affects the ability to maintain relationships and responsibilities.
In this partially manufacturer-sponsored, placebo-controlled trial, 551 patients who met DSM-IV criteria for chronic PTSD (including symptom clusters of re-experiencing the traumatic events, avoidance/numbing, and hyperarousal) were randomized to receive placebo (n=186), 20 mg/day of paroxetine (n=183), or 40 mg/day of paroxetine (n=182) for 12 weeks. Each group…